Implications of Withaferin A for the metastatic potential and drug resistance in hepatocellular carcinoma cells via Nrf2-mediated EMT and ferroptosis

References

• Ahmadian E, Pennefather PS, Eftekhari A, Heidari R, Eghbal MA. 2016. Role of renin-angiotensin system in liver diseases: an outline on the potential therapeutic points of intervention. Expert Rev Gastroenterol Hepatol. 10(11):1279–1288.
   PubMed Web of Science ®Google Scholar
• Almutlaq M, Alamro AA, Alamri HS, Alghamdi AA, Barhoumi T. 2021. The effect of local renin angiotensin system in the common types of cancer. Front Endocrinol. 12:736361.
   PubMed Web of Science ®Google Scholar
• Alnuqaydan AM, Rah B, Almutary AG, Chauhan SS. 2020. Synergistic antitumor effect of 5-fluorouracil and withaferin-A induces endoplasmic reticulum stress-mediated autophagy and apoptosis in colorectal cancer cells. Am J Cancer Res. 10(3):799–815.
   PubMed Web of Science ®Google Scholar
• Athreya K, Xavier MF. 2017. Antioxidants in the treatment of cancer. Nutr Cancer. 69(8):1099–1104.
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. 2018. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 68(6):394–424.
   PubMed Web of Science ®Google Scholar
• Cheng Z, Wei-Qi J, Jin D. 2020. New insights on sorafenib resistance in liver cancer with correlation of individualized therapy. Biochim Biophys Acta Rev Cancer. 1874(1):188382.
   PubMed Web of Science ®Google Scholar
• Costantini S, Colonna G, Castello G. 2014. A holistic approach to study the effects of natural antioxidants on inflammation and liver cancer. Cancer Treat Res. 159:311–323.
   PubMedGoogle Scholar
• Dongre A, Weinberg RA. 2019. New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer. Nat Rev Mol Cell Biol. 20(2):69–84.
   PubMed Web of Science ®Google Scholar
• Eftekhari A, Ahmadian E, Azarmi Y, Parvizpur A, Fard JK, Eghbal MA. 2018. The effects of cimetidine, N-acetylcysteine, and taurine on thioridazine metabolic activation and induction of oxidative stress in isolated rat hepatocytes. Pharm Chem J. 51(11):965–969.
   Web of Science ®Google Scholar
• Gao L, Wang X, Tang Y, Huang S, Hu CA, Teng Y. 2017. FGF19/FGFR4 signaling contributes to the resistance of hepatocellular carcinoma to sorafenib. J Exp Clin Cancer Res. 36(1):8.
   PubMedGoogle Scholar
• Gu J, Chen C, Wang J, Chen T, Yao W, Yan T, Liu Z. 2020. Withaferin A exerts preventive effect on liver fibrosis through oxidative stress inhibition in a sirtuin 3-dependent manner. Oxid Med Cell Longev. 2020:2452848.
   PubMed Web of Science ®Google Scholar
• Hassannia B, Logie E, Vandenabeele P, Vanden Berghe T, Vanden Berghe W. 2020. Withaferin A: from ayurvedic folk medicine to preclinical anti-cancer drug. Biochem Pharmacol. 173:113602.
   PubMed Web of Science ®Google Scholar
• Hassannia B, Wiernicki B, Ingold I, Qu F, Van Herck S, Tyurina YY, Bayir H, Abhari BA, Angeli JPF, Choi SM, et al. 2018. Nano-targeted induction of dual ferroptotic mechanisms eradicates high-risk neuroblastoma. J Clin Invest. 128(8):3341–3355.
   PubMed Web of Science ®Google Scholar
• Jadeja RN, Urrunaga NH, Dash S, Khurana S, Saxena NK. 2015. Withaferin-A reduces acetaminophen-induced liver injury in mice. Biochem Pharmacol. 97(1):122–132.
   PubMed Web of Science ®Google Scholar
• Kakar SS, Ratajczak MZ, Powell KS, Moghadamfalahi M, Miller DM, Batra SK, Singh SK. 2014. Withaferin a alone and in combination with cisplatin suppresses growth and metastasis of ovarian cancer by targeting putative cancer stem cells. PLoS One. 9(9):e107596.
   PubMed Web of Science ®Google Scholar
• Kulik L, El-Serag HB. 2019. Epidemiology and management of hepatocellular carcinoma. Gastroenterology. 156(2):477–491 e471.
   PubMed Web of Science ®Google Scholar
• Kyakulaga AH, Aqil F, Munagala R, Gupta RC. 2018. Withaferin A inhibits epithelial to mesenchymal transition in non-small cell lung cancer cells. Sci Rep. 8(1):15737.
   PubMedGoogle Scholar
• Lachaier E, Louandre C, Godin C, Saidak Z, Baert M, Diouf M, Chauffert B, Galmiche A. 2014. Sorafenib induces ferroptosis in human cancer cell lines originating from different solid tumors. Anticancer Res. 34(11):6417–6422.
   PubMed Web of Science ®Google Scholar
• Lee J, Liu J, Feng X, Salazar Hernandez MA, Mucka P, Ibi D, Choi JW, Ozcan U. 2016. Withaferin A is a leptin sensitizer with strong antidiabetic properties in mice. Nat Med. 22(9):1023–1032.
   PubMed Web of Science ®Google Scholar
• Liang C, Zhang X, Yang M, Dong X. 2019. Recent progress in ferroptosis inducers for cancer therapy. Adv Mater. 31(51):e1904197.
   PubMed Web of Science ®Google Scholar
• Liu Q, Qiao L, Liang N, Xie J, Zhang J, Deng G, Luo H, Zhang J. 2016. The relationship between vasculogenic mimicry and epithelial-mesenchymal transitions. J Cell Mol Med. 20(9):1761–1769.
   PubMed Web of Science ®Google Scholar
• Luo Q, Wang J, Zhao W, Peng Z, Liu X, Li B, Zhang H, Shan B, Zhang C, Duan C. 2020. Vasculogenic mimicry in carcinogenesis and clinical applications. J Hematol Oncol. 13(1):19.
   PubMed Web of Science ®Google Scholar
• Mallipeddi H, Thyagarajan A, Sahu RP. 2021. Implications of Withaferin-A for triple-negative breast cancer chemoprevention. Biomed Pharmacother. 134:111124.
   PubMed Web of Science ®Google Scholar
• Nezu M, Suzuki N, Yamamoto M. 2017. Targeting the KEAP1-NRF2 system to prevent kidney disease progression. Am J Nephrol. 45(6):473–483.
   PubMed Web of Science ®Google Scholar
• Roh JL, Kim EH, Jang H, Shin D. 2017. Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis. Redox Biol. 11:254–262.
   PubMed Web of Science ®Google Scholar
• Shin JA, Kim LH, Ryu MH, Choi SY, Jin B, Lee W, Jung YC, Ahn CH, Ahn MH, Hong KO, et al. 2022. Withaferin A mitigates metastatic traits in human oral squamous cell carcinoma caused by aberrant claudin-1 expression. Cell Biol Toxicol. 38(1):147–165.
   PubMed Web of Science ®Google Scholar
• Shiragannavar VD, Gowda NGS, Kumar DP, Mirshahi F, Santhekadur PK. 2020. Withaferin A acts as a novel regulator of liver X receptor-α in HCC. Front Oncol. 10:628506.
   PubMed Web of Science ®Google Scholar
• Siddharth S, Muniraj N, Saxena NK, Sharma D. 2019. Concomitant inhibition of cytoprotective autophagy augments the efficacy of Withaferin A in hepatocellular carcinoma. Cancers. 11(4):453.
   PubMed Web of Science ®Google Scholar
• Singal AG, Lampertico P, Nahon P. 2020. Epidemiology and surveillance for hepatocellular carcinoma: new trends. J Hepatol. 72(2):250–261.
   PubMed Web of Science ®Google Scholar
• Sun X, Ou Z, Chen R, Niu X, Chen D, Kang R, Tang D. 2016. Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells. Hepatology. 63(1):173–184.
   PubMed Web of Science ®Google Scholar
• Taguchi K, Yamamoto M. 2020. The KEAP1-NRF2 system as a molecular target of cancer treatment. Cancers. 13(1):46.
   PubMed Web of Science ®Google Scholar
• Tang W, Chen Z, Zhang W, Cheng Y, Zhang B, Wu F, Wang Q, Wang S, Rong D, Reiter FP, et al. 2020. The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects. Signal Transduct Target Ther. 5(1):87.
   PubMed Web of Science ®Google Scholar
• Thaiparambil JT, Bender L, Ganesh T, Kline E, Patel P, Liu Y, Tighiouart M, Vertino PM, Harvey RD, Garcia A, et al. 2011. Withaferin A inhibits breast cancer invasion and metastasis at sub-cytotoxic doses by inducing vimentin disassembly and serine 56 phosphorylation. Int J Cancer. 129(11):2744–2755.
   PubMed Web of Science ®Google Scholar
• Wang Q, Bin C, Xue Q, Gao Q, Huang A, Wang K, Tang N. 2021. GSTZ1 sensitizes hepatocellular carcinoma cells to sorafenib-induced ferroptosis via inhibition of NRF2/GPX4 axis. Cell Death Dis. 12(5):426.
   PubMed Web of Science ®Google Scholar
• Xiao X, Lu Z, Lin V, May A, Shaw DH, Wang Z, Che B, Tran K, Du H, Shaw PX. 2018. MicroRNA miR-24-3p reduces apoptosis and regulates Keap1-Nrf2 pathway in mouse cardiomyocytes responding to ischemia/reperfusion injury. Oxid Med Cell Longev. 2018:7042105.
   PubMed Web of Science ®Google Scholar
• Xu K, Shi H, Du Y, Ou J. 2021. Withaferin A inhibits proliferation of human endometrial cancer cells via transforming growth factor-β (TGF-β) signalling. 3 Biotech. 11(7):323.
   PubMedGoogle Scholar
• Yang JD, Hainaut P, Gores GJ, Amadou A, Plymoth A, Roberts LR. 2019. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol. 16(10):589–604.
   PubMed Web of Science ®Google Scholar
• Zhu YJ, Zheng B, Wang HY, Chen L. 2017. New knowledge of the mechanisms of sorafenib resistance in liver cancer. Acta Pharmacol Sin. 38(5):614–622.
   PubMed Web of Science ®Google Scholar